GKSL: MFTC “Uprising Curve” Signals a BIG Move?GKSL: MFTC “Uprising Curve” Signals a BIG Move?
Gujarat Kidney & Super Speciality Ltd. (GKSL) is showing a strong bullish structure on the daily timeframe, according to the MFTC Uprising Curve concept.
The stock has formed a clear upward-curving structure, with price consistently respecting the rising curve while creating higher highs and higher lows.
📈 MFTC Uprising Curve
One of the key MFTC observations is that when this Uprising Curve develops and price continues to respect the curve, it can
Pharmaceuticals
LLY: Daily Accumulation Breakout1. The Macro Perspective: The Multi-Month Accumulation Base
I am taking a LONG bias on Eli Lilly and Company (LLY) on the daily (1D) timeframe.
When analyzing pure market structure on a mega-cap pharmaceutical leader, prolonged consolidation periods are necessary to build kinetic energy for the next major thrust. Following its previous rally, the stock entered a massive horizontal digestion cycle spanning several months. This structure successfully absorbed profit-taking and allowed institutiona
CIPLA – 1D | Demand Reaction + Trendline Confluence Setup
After a strong impulsive decline from the 1520 supply zone, price tapped into the major daily demand (1280–1315) and is now consolidating above a rising trendline support.
We’re seeing early signs of base formation right at higher timeframe demand — a critical reaction zone.
📌 Setup Overview:
Entry Zone: 1330–1360 (pullback / breakout confirmation area)
Stop Loss: Below 1280 demand
Target: 1480–1520 supply
R:R: ~1:5 structure-based opportunity
Price is compressing below minor resistance
ERIS Lifesciences for 25% gainsDate: 3 Dec’24
Symbol: ERIS
Timeframe: Weekly
ERIS Lifesciences currently seems to be in Wave V of 3 which is heading towards 1960-70 (25% from current price of 1470) as seen in the chart. Wave 4 could then correct back to 1300 levels.
The company, in the recently announced September quarter results has posted best ever revenues and operating profits.
This is not a prediction but a possible wave count. This is also not a recommendation to trade or invest. Please do your own analysis.
HINGLIS
Jubilant Ingrevia for 60%+ gainsDate: 3 Oct’24
Stock: Jublingrea
Timeframe: Daily chart
Jubilant Ingrevia seems to be in Wave III of 3 which is heading towards 1300+ (60%+ from current price of 810) as seen in the chart. Wave III could end around 940 and Wave IV could correct to 750 levels (returns would be even higher if entered at the end of Wave IV of 3). High volume and strong RSI support this stance.
If the industry tailwinds remain, it won’t surprise me if the target is done in a year’s time.
This is not a trade reco
PPLPHARMAIMPORTANT POINTS
1. RSI - 60 CROSSED ON MONTHLY CHART
2. CUP BREAKOUT OVER ONE YEAR
3. SECTOR BREAKOUT
4. Trading at 35.2% below our estimate of its fair value
FUNDAMENTALS
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Neat and Clean Breakout seen in Pharmaceuticals companyHello Everyone, i hope you all will be doing good. I have brought an analysis on Pharmaceuticals stock which has given neat and clean short term consolidation zone breakout. Stock name is Alembic Pharmaceuticals and it is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
Leading Pharma company:-
The company has 3 R&D and 5 manufacturing facilities.
Alembic is among the top 25 players in domestic f
AARTI DRUGS - Price Observation & OverviewPrice Observation & Overview:
1. Currently reacting from the supply zone and trendline.
2. Volumes are dry!
3. Earnings are weak.
4. Buying strength is lacking at the moment.
Plan:
1. Wait and observer.
2. Will try to update a follow-up review post in the next week if found anything interesting and significant...
- Stay tuned for further insights, updates and trade safely!
- If you liked the analysis, don't forget to leave a comment and boost the post. Happy trading!
Disclaimer: This is N
Long Trade in Aarti Industries.NSE:AARTIIND
Long Trade in Aarti industries.
Best Buy ; Above 530+
Stop Loss: 490
Targets: 570/650/740/800/850/900+++
Reasons to Buy:
Breakout of Falling Wedge pattern.
Breakout with a good volume candle.
Above 530 there is good support from 200dma.
Good Risk to Reward Ratio.
Thanks & Happy Trading
Disclaimer:
This idea is only for educational purposes,
Please Trade at your own RISK''.
Small Rectangle pattern Breakout || Positional Trade in IPCA LABHello Guy's i have brought an idea which can be best positional trade as this stock has given breakout, i have done my analysis on daily time frame, Breakout is sustaining above the previous highs, Stock has made fresh all time high in today's session. Stock is good with good liquidity..
MACD also has given bullish crossover
Price and action suggesting a move at least for 8-10% in short term.
Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking a
INDSWFT LAB :- A STRONG BREAKOUT ON THE LINE NSE:INDSWFTLAB
Ind-Swift Laboratories Ltd. engages in the manufacture, development, and marketing of pharmaceutical ingredients. The firm operates throughout India and Outside India's geographical segments. Its products include API's and impurities. The firm supplies active pharmaceutical ingredients to pharmaceutical companies and also provides research and development services.
📊Technical analysis:
1. IT has formed a strong horizontal resistance at 125 zone from the last 13 years.
2. Now
Granules India: Breakout Confirmed, Long Opportunity EmergesAnalysis:
The chart of Granules India on TradingView suggests a promising breakout opportunity, potentially signaling a long entry chance for traders. Let's analyze the details based on the information provided on chart.
Current Price: ₹455.75, above the old year resistance level of ₹436.20 marked by the orange line.
Breakout Confirmation: The recent surge past the resistance zone, accompanied by strong volume, confirms a potential trend reversal from resistance to support.
Uptrend Mome
Natco Pharma: Sustained Breakout or Pullback Retest?Analysis:
The chart of Natco Pharma Ltd. on TradingView depicts an intriguing post-breakout scenario, presenting both potential long entry and cautious approaches for traders. Let's dissect the situation:
Current Price : ₹1026.50, well above the multi-year resistance level of ₹921.10 marked by the orange line.
Breakout Confirmation: The recent surge past the resistance zone, accompanied by strong volume, confirms a potential trend reversal from resistance to support.
Uptrend Momentum:
SMS Pharmaceuticals: Long Opportunity After Multi-Year BreakoutAnalysis:
The provided chart of SMS Pharmaceuticals (SMS Pharma) on TradingView reveals a potentially lucrative breakout opportunity. Let's break it down:
Current Price: ₹145.45, comfortably above the multi-year resistance level of ₹136 marked by the blue line.
Breakout Confirmation: The recent surge past the resistance zone, accompanied by strong volume, suggests a potential trend reversal from resistance to support.
Uptrend Momentum: The sustained price increase after the breakout ind
CIPLA Breakout Mini flag pattern 1. stock breakout resistance level almost 8th time
2. stock retest and create mini flag pattern (10.1.24 goods for interday)
3. stock close high price with green candle
4. volume also build
5. 1329 stock higher price since
6. entry should be 1330
7. target as per you planing
for my side 4% first target
8. Stop loss should resistance level where stock give breakout























